Search Results
Oct 06, 2025, 12:00 ET Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
Connecticut Avenue Securities, Series 2020-SBT1, Class 2M-2 Notes
More news about: Fannie Mae
Sep 29, 2025, 09:00 ET Fannie Mae Announces Tender Offer for Any and All of Certain CAS Notes
Connecticut Avenue Securities, Series 2020-SBT1, Class 2M-2 Notes
More news about: Fannie Mae
Sep 24, 2025, 10:45 ET InventHelp Inventor Develops Safe Cell Phone Accessory for Vehicles (SBT-2098)
National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-SBT-2098, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more
More news about: InventHelp
Sep 24, 2025, 10:30 ET InventHelp Inventor Develops New Therapeutic Belt (SBT-2088)
Diego sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-SBT-2088, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more
More news about: InventHelp
Sep 24, 2025, 10:15 ET InventHelp Inventor Develops New Horse Feeder Device (SBT-2075)
Diego sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-SBT-2075, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more
More news about: InventHelp
Sep 19, 2025, 20:07 ET Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
age-related macular degeneration and primary mitochondrial myopathy, and is developing its second-generation clinical-stage candidate, bevemipretide (SBT-272), for ophthalmic and neurological disease indications. Media ContactAscent Strategic CommunicationsAnna
More news about: Stealth BioTherapeutics Inc.
Sep 15, 2025, 10:00 ET 123Invent Inventor Develops New Topical Product to Relieve Pain (SBT-2244)
multimedia:https://www.prnewswire.com/news-releases/123invent-inventor-develops-new-topical-product-to-relieve-pain-sbt-2244-302556377.html
More news about: InventHelp